Last week a writer struggling with nightly snoring tried the Zeus, a dark grey adhesive that delivers tiny electrical pulses to the tongue‑controlling hypoglossal nerve. Developed by clinicians at Guy’s and St. Thomas’ NHS Foundation Trust and King’s College London,the device reportedly stopped the author’s snoring long enough for several uninterrupted hours of sleep.

Zeus relies on TENS to keep the hypoglossal nerve active

The Zeus gadget employs transcutaneous electrical nerve stimulation (TENS) aimed at the hypoglossal nerve, which normally lifts the tongue during breathing. By delivering micro‑currents through the skin, the device prevents the tongue from collapsing back and blocking the airway, a mechanism similar to that used in implanted hypoglossal stimulators for severe sleep apnea.

Clinical pedigree: Guy’s and St. Thomas’ NHS Trust and King’s College London

According to the product’s developers, the Zeus prototype emerged from a joint research program at Guy’s and St. Thomas’ NHS Foundation Trust and King’s College London, institutions known for pioneering sleep‑medicine trials. The partnership aimed to translate laboratory‑grade nerve‑stimulation into a consumer‑friendly, adhesive format that could be used without a prescription.

First‑hand results: several hours of uninterrupted sleep

As the author notes, the initial night with Zeus delivered “uninterrupted sleep for several hours,” a stark contrast to the frequent awakenings caused by snoring that had plagued them for months. The writer described the experience as a “remarkable improvement” and highlighted the device’s comfort, noting that the thin stick‑on adhered easily and caused no noticeable irritation.

Who else might benefit? Potential niche for mild to moderate snorers

While the report focuses on a single user, the technology could appeal to partners of snorers and individuals who find continuous positive‑air‑pressure (CPAP) machines too intrusive. If broader trials confirm efficacy, Zeus may fill a gap between simple mouth‑pieces and surgical interventions.

How does Zeus stack up against CPAP and implanted stimulators?

Open questions remain about the device’s long‑term effectiveness, especially compared with gold‑standard CPAP therapy and surgically implnated hypoglossal stimulators. The source does not provide data on nightly usage rates, side‑effects, or how the device performs across differrent sleep stages. Moreover, regulatory clearance and pricing details have yet to be disclosed.